|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Johnson & Johnson hiring Bayer exec for new post over consumer health, manufacturing and IT
Stephanie Link, director of research at TheStreet, says the move in Bristol Myers' stock from the suspension of a Hepatitis C compound has been overdone and sees value in the stock.
Stephanie Link, director of research at TheStreet, says CVS and Express Scripts are the real winners in Express Scripts' PBM agreement with Walgreen, and is buying CVS on today's pull back.
Stephanie Link, director of research at TheStreet, likes CVS for more than the market share they are gaining from Walgreen.
We'll trim a health care position and add to a consumer name and a tech holding.
SXC Health Solutions' acquisition of Catalyst Health Solutions adds to consolidation in the pharmacy benefits space.
Before you sacrifice a chunk of your cash to hedge fund managers' fees, try investing in their favorite picks.
US stocks fall after Federal Reserve policy minutes reveal dimmer outlook for jobs, growth
The FTC has approved a $29 billion acquisition by Express Scripts Deal for Medco Health Solutions.
Physicians in SEMI submitting more than 1 million prescriptions per month electronically
Medco Health Solutions (NYSE:MHS) hit a new 52-week high Wednesday as it is currently trading at $72.29, above its previous 52-week high of $70.97 with 7.8 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.
Study provides first evidence that pharmacogenetic testing can improve patient adherence to prescription drug therapy
Cramer says people will be surprised by the demand for copper.
More than One-in-Four Women take Medication to Treat a Mental Health Condition
New Medco study shows that, despite higher prescription rate, women fare worse in 25 out of 25 clinical measurements
Oral Cancer Drugs Need Added Monitoring to Prevent Safety Risks, Impaired Effectiveness
New data presentation from the first prospective study to explore the influence of pharmacogenetic testing on medication adherence and persistence
Medco Health Solutions (NYSE:MHS) is trading at unusually high volume Tuesday with 13.4 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up $2.13 (+3.1%).
Midas shares are surging in premarket trading Tuesday after TBC said it would buy the company for about $310 million.
A policy statement from the Fed and February retail sales are on tap Tuesday.
Medco Health Solutions (NYSE:MHS) hit a new 52-week high Friday as it is currently trading at $69.61, above its previous 52-week high of $69.10 with five million shares traded as of 12:50 p.m. ET. Average volume has been 3.3 million shares over the past 30 days.